African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 11, November 2025 | pp. 908–914

DOI: 10.46882/AJIDR/148893

Article Type: Research Article

Title: Molecular epidemiology and antifungal susceptibility of Histoplasma capsulatum in HIV-infected patients with disseminated histoplasmosis

Names of Authors: Sipho Ndlovu¹*, Lukas Fischer², Camila Ortega³

Authors’ Affiliations: ¹Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Mycology, University of Cologne, Cologne, Germany. ³Department of Microbiology, University of Antioquia, Medellín, Colombia.

Abstract: Progressive disseminated histoplasmosis frequently mimics miliary tuberculosis in severely immunocompromised HIV patients, resulting in delayed antifungal treatment and high mortality. We determined the prevalence and antifungal susceptibility of Histoplasma capsulatum among hospitalized adults with advanced HIV disease. Urine Histoplasma antigen enzyme immunoassays and bone marrow fungal cultures were performed for 240 patients with CD4 counts below 150 cells per microliter. Disseminated histoplasmosis was diagnosed in 15.8 percent of participants, with mucocutaneous lesions and pancytopenia serving as key clinical predictors. Liposomal amphotericin B induction followed by itraconazole significantly improved survival.

Keywords: Histoplasma capsulatum, Disseminated histoplasmosis, HIV/AIDS, Opportunistic mycoses, Antigen detection

Citation: Ndlovu S, Fischer L, Ortega C (2025). Molecular epidemiology and antifungal susceptibility of Histoplasma capsulatum in HIV-infected patients with disseminated histoplasmosis. African Journal of Infectious Diseases Research, 12(11): 908–914. DOI: 10.46882/AJIDR/148893

Manuscript Timeline: Received: September 20, 2025; Revised: October 21, 2025; Accepted: November 03, 2025; Published: November 09, 2025